Business Context and Reporting Period
Company: Lucid Diagnostics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 23, 2025
Reporting Period: The filing addresses events occurring on April 23, 2025, and references the fiscal years ended December 31, 2024, and 2023.
Key Financial Metrics
This filing does not contain specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on a change in the company's independent registered public accounting firm.
Material Changes
- Change in Certifying Accountant: Marcum LLP resigned as the independent registered public accounting firm on April 23, 2025. This resignation was solely due to the acquisition of Marcum's attest business by CBIZ CPAs P.C. on November 1, 2024.
- New Appointment: CBIZ CPAs P.C. was engaged as the new independent registered public accounting firm on April 23, 2025, with the approval of the audit committee.
- Audit History: Marcum's audit reports for the fiscal years ended December 31, 2024, and 2023, did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles. However, the reports included an explanatory paragraph regarding the Company's ability to continue as a going concern.
- Disagreements: There were no disagreements or reportable events between the Company and Marcum during the fiscal years ended December 31, 2024 and 2023, or through the date of resignation.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the going concern qualification noted in prior audit reports. The transition of the accounting firm is presented as a routine administrative change resulting from a third-party acquisition.
Investor Verification Checklist
- Verify the status of the "going concern" explanatory paragraph noted in the 2023 and 2024 audit reports to understand the Company's current liquidity position.
- Confirm the effective date of the engagement letter between Lucid Diagnostics and CBIZ CPAs.
- Review the letter from Marcum LLP (Exhibit 16.1) to ensure no undisclosed disagreements exist regarding the resignation.
- Monitor subsequent filings (e.g., 10-K or 10-Q) for the first financial statements audited or reviewed by CBIZ CPAs.